BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 29324471)

  • 1. Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.
    Johann PD; Bens S; Oyen F; Wagener R; Giannini C; Perry A; Raisanen JM; Reis GF; Nobusawa S; Arita K; Felsberg J; Reifenberger G; Agaimy A; Buslei R; Capper D; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Paulus W; Kool M; Hasselblatt M
    Am J Surg Pathol; 2018 Apr; 42(4):506-511. PubMed ID: 29324471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
    Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
    Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary atypical teratoid rhabdoid tumor in a patient with prolactinoma: A unique description.
    Barresi V; Lionti S; Raso A; Esposito F; Cannavò S; Angileri FF
    Neuropathology; 2018 Jun; 38(3):260-267. PubMed ID: 29110337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.
    Johann PD; Hovestadt V; Thomas C; Jeibmann A; Heß K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser P; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DTW; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
    Brain Pathol; 2017 Jul; 27(4):411-418. PubMed ID: 27380723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sellar Atypical Teratoid/Rhabdoid Tumor (AT/RT): A Clinicopathologically and Genetically Distinct Variant of AT/RT.
    Nakata S; Nobusawa S; Hirose T; Ito S; Inoshita N; Ichi S; Amatya VJ; Takeshima Y; Sugiyama K; Sonoda Y; Haga H; Hirato J; Nakazato Y; Yokoo H
    Am J Surg Pathol; 2017 Jul; 41(7):932-940. PubMed ID: 28338502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults.
    Thomas C; Wefers A; Bens S; Nemes K; Agaimy A; Oyen F; Vogelgesang S; Rodriguez FJ; Brett FM; McLendon R; Bodi I; Burel-Vandenbos F; Keyvani K; Tippelt S; Poulsen FR; Lipp ES; Giannini C; Reifenberger G; Kuchelmeister K; Pietsch T; Kordes U; Siebert R; Frühwald MC; Johann PD; Sill M; Kool M; von Deimling A; Paulus W; Hasselblatt M
    Acta Neuropathol; 2020 Feb; 139(2):277-286. PubMed ID: 31732806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor.
    Duan Z; Yao K; Yang S; Qu Y; Ren M; Zhang Y; Fan T; Zhao H; Gao J; Feng J; Fan X; Qi X
    Mod Pathol; 2022 Dec; 35(12):1910-1920. PubMed ID: 35804041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors.
    Frühwald MC; Hasselblatt M; Nemes K; Bens S; Steinbügl M; Johann PD; Kerl K; Hauser P; Quiroga E; Solano-Paez P; Biassoni V; Gil-da-Costa MJ; Perek-Polnik M; van de Wetering M; Sumerauer D; Pears J; Stabell N; Holm S; Hengartner H; Gerber NU; Grotzer M; Boos J; Ebinger M; Tippelt S; Paulus W; Furtwängler R; Hernáiz-Driever P; Reinhard H; Rutkowski S; Schlegel PG; Schmid I; Kortmann RD; Timmermann B; Warmuth-Metz M; Kordes U; Gerss J; Nysom K; Schneppenheim R; Siebert R; Kool M; Graf N
    Neuro Oncol; 2020 Jul; 22(7):1006-1017. PubMed ID: 31883020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical Teratoid/Rhabdoid Sellar Tumor in an Adult with a Familial History of a Germline SMARCB1 Mutation: Case Report and Review of the Literature.
    Voisin MR; Ovenden C; Tsang DS; Gupta AA; Huang A; Gao AF; Diamandis P; Almeida JP; Gentili F
    World Neurosurg; 2019 Jul; 127():336-345. PubMed ID: 31004861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.
    Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M
    J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous Regression of Atypical Teratoid Rhabdoid Tumor Without Therapy in a Patient With Uncommon Regional Inactivation of SMARCB1 ( hSNF5/INI1).
    Peterson JEG; Bavle A; Mehta VP; Rauch RA; Whitehead WE; Mohila CA; Su JM; Adesina AM
    Pediatr Dev Pathol; 2019; 22(2):161-165. PubMed ID: 30470167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
    Alimova I; Pierce A; Danis E; Donson A; Birks DK; Griesinger A; Foreman NK; Santi M; Soucek L; Venkataraman S; Vibhakar R
    Int J Cancer; 2019 Apr; 144(8):1983-1995. PubMed ID: 30230537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous.
    Pinto EM; Hamideh D; Bahrami A; Orr BA; Lin T; Pounds S; Zambetti GP; Pappo AS; Gajjar A; Agnihotri S; Broniscer A
    Acta Neuropathol; 2018 Aug; 136(2):315-326. PubMed ID: 29428974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance.
    Federico A; Thomas C; Miskiewicz K; Woltering N; Zin F; Nemes K; Bison B; Johann PD; Hawes D; Bens S; Kordes U; Albrecht S; Dohmen H; Hauser P; Keyvani K; van Landeghem FKH; Lund EL; Scheie D; Mawrin C; Monoranu CM; Parm Ulhøi B; Pietsch T; Reinhard H; Riemenschneider MJ; Sehested A; Sumerauer D; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
    Acta Neuropathol; 2022 Jun; 143(6):697-711. PubMed ID: 35501487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohort.
    Benesch M; Nemes K; Neumayer P; Hasselblatt M; Timmermann B; Bison B; Ebetsberger-Dachs G; Bourdeaut F; Dufour C; Biassoni V; Morales La Madrid A; Entz-Werle N; Laithier V; Quehenberger F; Weis S; Sumerauer D; Siebert R; Bens S; Schneppenheim R; Kool M; Modena P; Fouyssac F; C Frühwald M
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28022. PubMed ID: 31571386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup.
    Zin F; Cotter JA; Haberler C; Dottermusch M; Neumann J; Schüller U; Schweizer L; Thomas C; Nemes K; Johann PD; Kool M; Frühwald MC; Paulus W; Judkins A; Hasselblatt M
    Brain Pathol; 2021 Sep; 31(5):e12967. PubMed ID: 33938067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes.
    Johann PD; Erkek S; Zapatka M; Kerl K; Buchhalter I; Hovestadt V; Jones DTW; Sturm D; Hermann C; Segura Wang M; Korshunov A; Rhyzova M; Gröbner S; Brabetz S; Chavez L; Bens S; Gröschel S; Kratochwil F; Wittmann A; Sieber L; Geörg C; Wolf S; Beck K; Oyen F; Capper D; van Sluis P; Volckmann R; Koster J; Versteeg R; von Deimling A; Milde T; Witt O; Kulozik AE; Ebinger M; Shalaby T; Grotzer M; Sumerauer D; Zamecnik J; Mora J; Jabado N; Taylor MD; Huang A; Aronica E; Bertoni A; Radlwimmer B; Pietsch T; Schüller U; Schneppenheim R; Northcott PA; Korbel JO; Siebert R; Frühwald MC; Lichter P; Eils R; Gajjar A; Hasselblatt M; Pfister SM; Kool M
    Cancer Cell; 2016 Mar; 29(3):379-393. PubMed ID: 26923874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor.
    Thomas C; Oehl-Huber K; Bens S; Soschinski P; Koch A; Nemes K; Oyen F; Kordes U; Kool M; Frühwald MC; Hasselblatt M; Siebert R
    Genes Chromosomes Cancer; 2021 Aug; 60(8):586-590. PubMed ID: 33896072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.
    Pathak R; Zin F; Thomas C; Bens S; Gayden T; Karamchandani J; Dudley RW; Nemes K; Johann PD; Oyen F; Kordes U; Jabado N; Siebert R; Paulus W; Kool M; Frühwald MC; Albrecht S; Kalpana GV; Hasselblatt M
    Acta Neuropathol; 2021 Aug; 142(2):361-374. PubMed ID: 34003336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities.
    Paassen I; Williams J; Ríos Arceo C; Ringnalda F; Mercer KS; Buhl JL; Moreno N; Federico A; Franke NE; Kranendonk M; Upadhyaya SA; Kerl K; van de Wetering M; Clevers H; Kool M; Hoving EW; Roussel MF; Drost J
    Oncogene; 2023 May; 42(20):1661-1671. PubMed ID: 37020038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.